上海
分享至
据报道，谷歌DeepMind分拆出来的AI驱动药物研发公司Isomorphic Labs正深入洽谈，计划在新一轮融资中筹集超过20亿美元。知情人士称，曾主导Isomorphic Labs去年首轮融资的风投机构Thrive Capital将牵头本轮新融资，Alphabet也将参与。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
